Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1977 3
1978 3
1979 4
1980 6
1981 4
1982 3
1983 6
1984 4
1985 3
1987 2
1988 4
1989 3
1990 1
1991 2
1993 1
1994 1
1995 2
1996 3
1997 5
1998 4
1999 2
2000 2
2001 7
2002 9
2003 14
2004 13
2005 12
2006 20
2007 10
2008 13
2009 9
2010 12
2011 8
2012 3
2014 1
2015 1
2016 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

186 results

Results by year

Filters applied: . Clear all
Page 1
[18F]FETO: metabolic considerations.
Ettlinger DE, Wadsak W, Mien LK, Machek M, Wabnegger L, Rendl G, Karanikas G, Viernstein H, Kletter K, Dudczak R, Mitterhauser M. Ettlinger DE, et al. Among authors: kletter k. Eur J Nucl Med Mol Imaging. 2006 Aug;33(8):928-31. doi: 10.1007/s00259-006-0123-5. Epub 2006 May 11. Eur J Nucl Med Mol Imaging. 2006. PMID: 16688452
Prognostic value of FDG-PET in malignant lymphoma.
Becherer A, Jaeger U, Szabo M, Kletter K. Becherer A, et al. Among authors: kletter k. Q J Nucl Med. 2003 Mar;47(1):14-21. Q J Nucl Med. 2003. PMID: 12714950 Free article. Review.
[18F]FE@SUPPY and [18F]FE@SUPPY:2--metabolic considerations.
Haeusler D, Nics L, Mien LK, Ungersboeck J, Lanzenberger RR, Shanab K, Spreitzerf H, Sindelar KM, Viernstein H, Wagner KH, Dudczak R, Kletter K, Wadsak W, Mitterhauser M. Haeusler D, et al. Among authors: kletter k. Nucl Med Biol. 2010 May;37(4):421-6. doi: 10.1016/j.nucmedbio.2010.01.001. Epub 2010 Mar 6. Nucl Med Biol. 2010. PMID: 20447552
FDG-PET in adrenocortical carcinoma.
Becherer A, Vierhapper H, Pötzi C, Karanikas G, Kurtaran A, Schmaljohann J, Staudenherz A, Dudczak R, Kletter K. Becherer A, et al. Among authors: kletter k. Cancer Biother Radiopharm. 2001 Aug;16(4):289-95. doi: 10.1089/108497801753131363. Cancer Biother Radiopharm. 2001. PMID: 11602999
Pharmacoresistance in epilepsy: a pilot PET study with the P-glycoprotein substrate R-[(11)C]verapamil.
Langer O, Bauer M, Hammers A, Karch R, Pataraia E, Koepp MJ, Abrahim A, Luurtsema G, Brunner M, Sunder-Plassmann R, Zimprich F, Joukhadar C, Gentzsch S, Dudczak R, Kletter K, Müller M, Baumgartner C. Langer O, et al. Among authors: kletter k. Epilepsia. 2007 Sep;48(9):1774-1784. doi: 10.1111/j.1528-1167.2007.01116.x. Epub 2007 May 1. Epilepsia. 2007. PMID: 17484754 Free article.
Imaging of adrenocortical metastases with [11C]metomidate.
Mitterhauser M, Dobrozemsky G, Zettinig G, Wadsak W, Vierhapper H, Dudczak R, Kletter K. Mitterhauser M, et al. Among authors: kletter k. Eur J Nucl Med Mol Imaging. 2006 Aug;33(8):974. doi: 10.1007/s00259-006-0103-9. Epub 2006 May 24. Eur J Nucl Med Mol Imaging. 2006. PMID: 16721573 No abstract available.
Peripheral metabolism of (R)-[11C]verapamil in epilepsy patients.
Abrahim A, Luurtsema G, Bauer M, Karch R, Lubberink M, Pataraia E, Joukhadar C, Kletter K, Lammertsma AA, Baumgartner C, Müller M, Langer O. Abrahim A, et al. Among authors: kletter k. Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):116-23. doi: 10.1007/s00259-007-0556-5. Epub 2007 Sep 11. Eur J Nucl Med Mol Imaging. 2008. PMID: 17846766 Clinical Trial.
186 results